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Abstract
Regulatory gene circuits enable stem and progenitor cells to detect and process developmental
signals and make irreversible fate commitment decisions. To gain insight into the gene circuits
underlying the T-cell specification decision in progenitor cells, we generated an updated T
lymphocyte developmental gene regulatory network from genes and connections found in the
literature. This reconstruction allowed us to identify candidate regulatory gene circuit elements
underlying T-cell fate decision making. Here, we examine the roles of these circuits in facilitating
different aspects of the decision making process, and discuss experiments to further probe their
structure and function.
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Haematopoietic stem and progenitor cells utilize networks of interacting genes and proteins
to make cell fate decisions. Regulatory gene circuits within these networks enable
progenitors to sense and process external developmental signals, choose between alternate
competing fates, and irreversibly commit to a single fate once a decision has been made. The
connectivity between genes constituting a circuit determines its dynamic behavior and
function, and specific connectivity patterns, or motifs, are thought to enable cells to perform
specific tasks and operations [1]. Circuits with positive feedback loops can generate multiple
stable cellular states, and mediate irreversible commitment in a variety of developmental
contexts, including haematopoietic fate decision making [2-5]. On the other hand, negative
feedback loops and feed-forward loops can perform different processing operations on input
signals [6, 7], and has been proposed to operate in a variety of signaling pathways [8, 9]. We
here review the underlying gene network structure that contributes to a particularly intricate
cell fate decision, the decision of haematopoietic progenitors to abandon other
developmental options and undertake the T-lymphocyte fate.
Outline of T-cell development
T cell lineage identity is forged by a gene regulatory network that is initially triggered by
environmental signals (Figure 1). Haematopoietic progenitors begin T-cell development as
they enter the thymus and activate the Notch-Delta signaling pathway in response to a Delta
family molecule in the thymic stroma (Notch ligand, probably Delta-like 4) [10, 11]. Upon
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sustained exposure to Notch-Delta signaling, progenitors enter a developmental stage where
they up-regulate certain T-cell identity genes, but maintain expression of stem-cell genes
and plasticity to some alternative fates (DN2A, [12]). We will refer to these two pre-
commitment stages of T-cell development collectively as the Phase 1 stage (Figure 1, [13]).
Upon further Notch-Delta signaling, progenitors undergo commitment to the T-cell fate,
undergo major changes in their gene regulatory state (DN2B), and eventually re-arrange T-
cell receptor genes (DN3). We will refer to these post-commitment stages collectively as the
Phase 2 stage. Sustained Notch-Delta signaling across Phase 1 is required for fate
commitment: progenitors transiently exposed to Delta-ligand can turn on T-cell genes, but
fail to undergo commitment and may instead differentiate into other lineages, including
dendritic, myeloid and NK cells and initially B cells as well [12, 14-22]. Note that Notch
signaling first inhibits and then excludes all these non-T fate alternatives at different
developmental stages, through distinct regulatory mechanisms, the details of which are
reviewed elsewhere [23]. After commitment, Notch signals remain important for viability
support and then become dispensable.
The ability to commit only upon sustained signaling may reflect the action of coherent feed-
forward regulatory circuits, where a signal regulates a target gene both through a direct input
and also indirectly through an intermediate regulator (Figure 2A). Coherent feed-forward
loops act as persistence detectors, allowing cells to filter out transient signals and respond
only to sustained stimulation [24, 25]. In T-cell progenitors, different Notch target genes can
show very different induction kinetics after the onset of Notch-Delta signaling [15],
consistent with the existence of coherent feed-forward loops regulating their expression.
Besides Delta ligand, cytokines from the thymic microenvironment (i.e. Kit ligand,
interleukin (IL)-7, and possibly also thymic stromal lymphopoietin) play critical roles in
early T-cell development [26, 27]. Flt3 ligand is also very important for prethymic
precursors, although its role within the thymus proper is less clear. While these cytokines are
primarily thought to support viability and proliferation of early progenitors (Figure 1), recent
work suggests that dynamic IL-7 signals may also play a major role in regulating the
commitment transition itself [28]. The IL-7 signaling pathway may be inactive in the earliest
T-cell progenitors (ETP) [29-31], but is strongly activated in uncommitted DN2 progenitors,
in which it supports survival and proliferation [32]. It is then inactivated after commitment
[33-35], possibly also affected by cell non-autonomous mechanisms [36]. Recently, Ikawa
and colleagues found in a feeder-free in vitro system that a reduction of IL-7 signal levels
promoted the commitment of uncommitted DN2 progenitors [28]. Progenitors experiencing
uniform IL-7 levels remained arrested at the DN2 stage and retained the potential to undergo
myeloid differentiation. These results suggest that T-cell progenitors can sense changes in
IL-7 signaling activity and make commitment decisions accordingly.
How do cells perceive changes in external signal levels? Both the negative feedback loop
and the incoherent feedforward loop can, under certain parameter regimes, show sensitivity
not to absolute levels of upstream signal, but to changes in the level of signal [6, 7]. In a
negative feedback loop, a signal activates a downstream target, which in turn feeds back to
negatively modulate the signaling pathway’s sensitivity to signal (Figure 2B) In an
incoherent feedforward loop, the signal regulates a downstream target through two different
connections that have opposing signs (Figure 2C). Both these circuits can adjust their
regulatory state to maintain sensitivity to signal level changes over a range of signal
strengths, a phenomenon known as adaptation. Such regulatory circuit motifs may play a
role in sensing IL-7 level changes during T-cell fate decision making.
By committing to the T-cell fate, progenitors suppress alternate fates and stably express T-
cell identity genes, features that are subsequently maintained even after withdrawal of
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environmental signals. Stable maintenance of fate identity in committed progenitors is
thought to arise through the action of positive feedback loops. These positive feedback loops
are engaged or triggered in response to upstream signaling inputs (i.e. Notch and IL-7
signaling in the case of T-cell development), and stably maintain a cell regulatory state even
if these signaling inputs are withdrawn. In a developmental context, positive feedback loops
may consist of a cycle of activating connections, either from a single fate identity gene onto
itself, or between multiple fate identity genes (Figure 2D, top). Such loops enable self-
sustaining expression of fate-identity genes in the absence of signaling inputs, and occur
frequently in embryonic gene regulatory networks [5, 37]. They have also been found in the
context of early B-cell development [38, 39]. Alternatively, positive feedback loops may be
built from mutually repressive connections between genes associated with alternate fates
(Figure 2D, bottom). Several well-studied hematopoietic cell fate decisions can also be
explained by minimal gene regulatory networks in which mutual repression between two
transcriptional regulators forms the core. These apparently govern binary choices between
erythroid and myeloid fates [3, 40, 41], between granulocyte and macrophage fates [4], and
between myeloid and B-cell fates [42].
The decision of a precursor to become a T cell appears to be more complex in regulatory
terms. In particular, more than one alternative fate is excluded by the T lineage commitment
process, arguing against a simple binary switch decision mechanism. Even so, the early T-
cell transcription factor repertoire includes regulatory genes that either activate other T-cell
genes or repress non-T genes, and could thus participate in these positive feedback loops to
maintain T-cell identity. Recent studies have identified the T-cell specific transcription
factors TCF-1 and Bcl11b as key regulators of T-cell specification and commitment [28,
43-45]. Interestingly, these two transcription factors appear to perform complementary
functions during T-cell development - TCF-1 acts to turn on T-cell specific genes, whereas
Bcl11b may primarily function to repress alternate fate genes. However, it is still unclear
how TCF-1, Bcl11b and other T-cell fate regulators interact with each other and work
together on a circuit level to maintain fate identity in committed T-cell progenitors.
To gain insight into the regulatory gene circuits mediating the T-cell fate decision, we
present here a new construction of the gene regulatory network that guides T-cell
development. This reconstruction builds upon an earlier model of regulatory network
interactions during T-cell commitment [46], and incorporates recently-identified genes and
connections. This network reconstruction enables us to identify candidate regulatory circuits
that may play roles in processing developmental signals and maintaining stable T-cell
identity. We speculate on the functional significance of these regulatory circuits, and discuss
further experiments that would enable us to examine their structure and function.
Data for a T-cell specification network model
T cell developmental progression depends not only on environmental signals, but also on
temporally and quantitatively precise control of transcription factor activities. The same
factors have different roles at different stages, and their effects in any given stage can
depend sensitively upon level of expression. For example, several crucial regulatory genes
are haploinsufficient, while the same factors that are required at a given stage can inhibit
that same stage if they are overexpressed. This makes it challenging to design the
experimental perturbations that are needed to evaluate regulatory network connections.
Ideally, the immediate gene-expression consequences of changing the activity of a
regulatory factor should be monitored within a well-defined developmental stage when the
only difference from the control is the one targeted molecule. Ideally also, gain of function
tests, which induce their effects quickly, should stay within a dosage range that is
physiologically relevant, to avoid off-target effects.
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The strategies used to generate samples for analysis of the T-cell gene network are
summarized in Figure 3, where the caveats of different perturbation strategies within
developmental stages of interest (Figure 3A) are noted. Germline or conditional knockout
phenotypes in vivo are often regarded as a gold standard for assessing loss of function
effects in otherwise normal conditions; however, the in vivo steady state is often
complicated by compensatory mechanisms or more profound developmental deviation
(Figure 3B, yellow circle), especially if deletion occurs long before the stage being assayed,
and under these circumstances inference of regulatory gene connections is not reliable. In
vitro differentiation systems for T-cell development allow for a wide variety of perturbations
to be applied in a more stage-specific manner [47]. These systems allow for stage-specific
addition or removal of environmental signals and gene over-expression, as well as deletion
or neutralization of endogenous genes by transgenic expression of recombinase, retroviral
introduction of recombinase, or introduction of shRNA (Figure 3C). Even in these more
accessible systems, in order to identify direct regulatory connections reliably, the effects of
such perturbations on downstream gene expression must be measured before uncontrolled
changes in cell-type identity occur (Figure 3C, yellow circle). Measurements of gene
expression changes in response to regulatory gene deletion or neutralization can be
particularly difficult to time, as additional factors such as protein and mRNA stability may
cause a time-delay in the loss of transcriptional factor activity.
One recent tool that will have a large impact on network modeling is genome-wide analysis
of transcription factor binding, as measured by chromatin immune precipitation and
microarray hybridization (ChIP-chip) or deep sequencing (ChIP-seq) (e.g. [48-51]). The data
are extremely useful to reveal where the binding sites may be through which a particular
transcription factor acts on a particular target gene. However, binding alone does not tell
whether a factor is acting as activator or repressor. Furthermore, it is emerging from these
studies that there are often thousands of genomic sites bound by particular factors where,
despite exquisite sequence-specificity, the factors exert no detectable regulatory influence at
all. ChIP-chip and ChIP-seq evidence is still far from superseding the need to use actual
experimental perturbations to determine a factor’s functional effects. It is the combination of
direct, stage-specific measurements of protein/DNA binding together with functional data
that will ultimately enable solution of the T-cell network in a definitive form.
The data sources used for this T-cell network reconstruction are listed in Supplementary
Table 1, together with the approaches used to evaluate regulatory network linkages in each
study [28, 35, 42, 44, 52-96]. In fact, all the available data sources on which T-cell network
construction must currently be based include compromises with ideal conditions. As a result,
the network relationships described here should still be regarded as a model and a guide to
further experimental work.
Reconstruction of a T-Cell Developmental Network Model
The network model focuses on regulatory genes and connections that are active in the Phase
1 and 2 pro-T cell stages (Figure 1), i.e., from when cells begin to respond to Notch signals
to after they commit to becoming T-cells. To build this network, we first searched the
literature for recently-identified genes and connections, as listed in Table 1. We obtained
most of the genes and connections for our regulatory network from experiments done on
mouse models of fetal or adult haematopoiesis; we do note, however, that there may be
differences in the regulatory circuit architecture that have arisen during the course of
evolution or even between adult development and ontogeny. These nodes and edges were
then combined with relationships from an earlier model of the network [46]. Network
building was performed using Biotapestry [97, 98], a software for the representation and
visualization of developmental gene regulatory networks.
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Genes in the T-cell developmental network can be divided into the following groups broadly
based on their function and expression patterns [13] (Figure 4): (1) Effectors or regulators of
Notch, IL-7 and pre-TCR signaling, three signaling pathways that are important for early T-
cell development (top). (2) Regulatory genes associated with T-cell developmental stage
progression and fate commitment (middle). These genes are either up-regulated during the
course of development (e.g. Bcl11b and Lef1) or kept at a constant expression level during
the developmental stage progression (e.g. Ikaros and Runx1). (3) Regulatory genes that are
down-regulated during T-cell development, and are associated with the either stem cells or
non T-cell fates (bottom). Genes in this group generally antagonize T-cell developmental
stage progression and commitment; however, some of them are also necessary for T-cell
production in vivo as they play important roles at the stem or early progenitor stages (e.g.
PU.1). Thus, the down-regulated group may actually comprise two subgroups: one
consisting of the drivers of competing fates, but the other consisting of genes that sustain
proliferation or other functions of early T cells while delaying commitment [13].
Genes within each of these functional groups are further arranged from left to right based on
the temporal sequence of expression and/or activity level changes during T-cell development
(Figure 4). At the top left are Notch and IL-7 signaling pathway components (e.g. IL-7Rα
and Notch1), which are active prior to T-cell commitment (Phase 1, Figure 4); components
required for the pre-TCR signaling pathway (e.g. pTα, Tcr-β and Lck), which are T-cell
specific genes turned on only after commitment (Phase 2, Figure 4), are placed to the right.
Within the T-cell regulatory gene group (middle), the left hand cluster contains genes
already expressed prior to commitment (e.g. Gata3, Ikaros and Runx1), while genes up-
regulated after commitment are placed towards the right (e.g. Id3 and Ets1). A number of
regulatory genes are up-regulated sharply immediately prior to commitment (e.g. Bcl11b
and HEB-Alt); these genes, poised to promote T-cell fate commitment, are placed in the
center and boxed. Stem and alternate fate regulatory genes are placed at the bottom, with
those already being silenced prior to commitment to the left (e.g. Gata2, C/EBPα and Ebf1),
and those not down-regulated until after commitment in the center and right (e.g. PU.1, Lyl1
and Kit).
We note that, besides Notch and IL-7, a number of other cytokine signaling pathways – such
as the Kit or the Flt3 pathway – may also be important for the viability and proliferation of
uncommitted Phase I progenitors (Figure 1). All stages of T-cell development require
viability functions, however, and in this network reconstruction, we have not included cell
cycle or apoptosis genes regulated by these pathways (or by the Notch or IL-7 pathways
themselves). This network model instead focuses on the regulatory genes that have been
implicated in the commitment transition itself. Nevertheless, Kit signaling could also
contribute to the Stat activation function in parallel with IL7Rα in Phase 1 cells. Similarly,
although the crucial T-lineage transcription factors TCF-1 (encoded by Tcf7) and Lef1 have
important roles as mediators of Wnt/β-catenin signaling, their roles in early T-cell
development may not depend on this pathway [99], and so Wnt pathway inputs have also
been omitted.
Genes in the T-cell developmental network interact extensively with one another, and
specific patterns of connections within or between functional groups can be observed (see
Figure 4 inset for a summary). The Notch-Delta signaling pathway provides direct or
indirect positive regulatory inputs into many T-cell regulatory genes, including those
activated at the earliest stages, consistent with its role in promoting T-cell fate. It also
positively regulates genes encoding IL-7, Notch and pre-TCR signaling pathway
components. Nevertheless, some pre-TCR signaling pathway genes, although directly
targeted by Notch, turn on only after commitment. These reflect a requirement for persistent,
sustained Notch signals to complete proper T-cell fate commitment, most likely enforced by
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network subcircuit architecture as described below. In contrast, IL-7 signaling may
negatively regulate T-cell regulatory genes (Bcl11b, TCF-1 and Lef1) in uncommitted DN2
cells, either directly or indirectly, as well as positively regulate stem and alternate fate genes
(Kit, PU.1 and C/EBPα), consistent with its role in antagonizing or at least delaying
commitment [28].
T-cell regulatory genes generally provide positive inputs into Notch and pre-TCR signaling
genes (e.g. Gata3–Notch3; E protein activity–pTα; Runx1-Tcr–β), positive inputs into other
T-cell regulatory genes (e.g. TCF-1–Bcl11b; HEBAlt–HEBAlt), and/or negative inputs into
stem and alternate fate genes (e.g. Bcl11b–Id2; Gata3–PU.1, Runx1–PU.1), consistent with
their roles in promoting the T-cell fate and repressing alternate cell fates. However, we
found that several T-cell regulatory genes, most notably the crucial transcription factor
Gata3, can also form negative connections with other T-cell regulatory genes (e.g. Gata3–
Lef1, Gata3–TCF-1, E protein activity–Gata3), while forming positive connections with
stem and alternate fate genes (e.g. Gata3–Scl/Tal1, Gata3–Kit, Gata3–Cpa3), especially
when overexpressed. Such ‘incoherent’ connections may constitute part of the regulatory
circuitry involved in sensing IL-7 signal changes during development (see below). Stem and
alternate fate regulatory genes generally form negative connections with T-cell regulatory
genes and pre-TCR signaling genes (e.g. Gfi1b–Gata3; PU.1–Bcl11b; Scl/Tal1–pTα) and
positive connections amongst themselves (PU.1–Bcl11a; Lmo2–Lyl1), consistent with their
role in delaying or antagonizing the T-cell fate and promoting stem and alternate fates.
Regulatory Circuits Underlying the T-Cell Fate Decision
The reconstructed T-cell gene regulatory network presented above enables us to identify
regulatory circuits that are important for T-cell fate decision making. In this section, we use
the reconstructed network to identify candidate regulatory circuits that may facilitate three
crucial aspects of the fate decision making process: 1) Detection of persistence in Notch-
Delta signaling in early multipotent progenitors, 2) Detection of dynamic changes in IL-7
signaling in uncommitted T-cell progenitors, and 3) Maintenance of T-cell identity and
silencing of alternate cell fates in committed progenitors.
Detection of Persistence in Notch Signaling
Proper commitment to the T-cell fate requires sustained Notch-Delta signaling throughout
the Phase 1 stage. Transient Notch-Delta signaling causes up-regulation of early T-cell
genes, but is insufficient for promoting commitment [14, 15]. Detection of such signal
persistence can be performed by coherent feed-forward loops, which can generate time
delays using multiple inputs from a signal onto a target gene. In the coherent feedforward
loop example shown (Figure 2A), a signal S provides a positive input into a target gene Y,
and also into another gene X that provides another input into Y. In order for Y to be
completely unresponsive to transient signals, it must be respond to X and S with strict AND
logic (that is, both S and X must be on for Y to be on). We note, however, that persistence
detection can still take place even if X and S do not operate in such a boolean manner, but
synergize to up-regulate Y; or, alternatively, if heightened threshold levels of Y, attained
only when X and S are both present, are required for promoting downstream developmental
transitions.
Our regulatory network reconstruction reveals several coherent feed-forward loops that may
mediate the response of T-cell regulatory genes to Notch signaling. Bcl11b, an important
regulator of T-cell commitment, is thought to be a direct Notch target [44]; however, it
remains off even when other Notch target genes such as CD25 and Hes1 have already turned
on in response to Notch-Delta signaling [15, 28, 100], and turns on only immediately prior
to commitment. In our network re-construction, the Notch signaling-induced gene TCF-1
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provides a second arm of positive inputs from Notch to Bcl11b (Figure 5A, left), which may
provide the time-delayed inputs that enable Bcl11b to respond only after sustained and
persistent Notch signaling. There is also a similar coherent feed-forward loop regulating
GATA3 expression (Figure 5A) 1, which may possibly mediate the up-regulation of GATA3
that occurs post-commitment [101]. We also found that the T-cell identity genes pTα and
Rag-1 may also be subject to coherent feedforward regulation through E protein activity
(Figure 5A, right). In a third possible example (not shown), Notch-induced TCF-1 can
provide direct positive input into a major promoter of the Notch-dependent gene Lef1 [102].
This regulatory circuit architecture may explain why these genes, though being Notch
targets, do not turn on until after T-cell commitment. Interestingly, TCRβ, another T-cell
identity gene that is up-regulated only after commitment, does not appear to receive inputs
directly from Notch signaling, but only indirectly through Gata3 (Figure 5A, right),
suggesting that not all T-cell identity genes may be subject to such coherent feedforward
regulation.
To establish whether a given gene is indeed subject to such coherent feed-forward
regulation, we need to demonstrate that it receives two independent inputs, and that it turns
on only when both are present. As evidence for direct regulation is currently lacking in
many of the feedforward inputs discussed above (Figure 5, dashed and dotted lines), it is not
known whether the two inputs into the target genes are indeed independent --- an apparent
feedforward input into a target gene could turn out to be an indirect input mediated
completely through the second coincident input. We will discuss experiments that could
distinguish between these two possibilities below.
Detection of Dynamic IL-7 Signaling
Besides persistent Notch signaling, recent work suggests that a drop in IL-7 signal levels can
promote fate commitment in uncommitted DN2 progenitors [28]. Detecting input signal
changes requires circuits that can adapt to different baseline levels and thus maintain
sensitivity to signal level changes over a range of signal strengths. Two types of regulatory
circuits are capable of undergoing such adaptation – negative feedback loops and incoherent
feedforward loops [7]. Negative feedback loops perform adaptation by altering a signaling
pathway’s sensitivity to signal inputs in response to the input signal itself. Negative
feedback connections can occur directly through biochemical interactions within a signaling
pathway, as is frequently observed [103], or indirectly through transcriptional regulation of
signaling pathway components. In an example of the latter (Figure 2B), signal S provides a
positive input into X, which is an inhibitory component of the S signaling pathway.
Incoherent feedforward loops perform adaptation through independent opposing inputs from
a signal onto a target gene. In the example shown (Figure 2C), gene Y receives a positive
input from a signal S, but also receives a negative input from gene X, which also receives a
positive input from S. These two opposing regulatory inputs into Y can cancel each other out
at steady state, allowing the circuit to maintain a constant level of Y amidst different baseline
values of S, and hence maintain sensitivity to signal level changes over a range of signal
changes.
Negative feedback loops in IL-7 signaling may occur either within the signaling pathway
itself or on a transcriptional level. Negative feedback within the IL-7 signaling pathway
could be mediated by SOCS1, a general suppressor of cytokine signaling that is induced in
T-cell precursors in response to IL-7 [104]. An alternative mode of negative feedback may
involve internalization and degradation of the IL-7 receptor, which has been shown to be
1Regulation of GATA3 by Notch signaling may be indirect and/or specific to a mouse context, as studies using human thymocytes did
not identify GATA3 as a Notch target [111-112].
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triggered by IL-7 ligand binding [105, 106]. Examination of the regulatory network also
revealed a potential transcriptional circuit that involves negative feedback regulation of
IL-7Rα, the receptor chain that receives IL-7 signals (Figure 5B, top). IL-7 signaling may
provide a positive input into GATA-3. GATA-3 in turn appears to provide negative
regulatory inputs into IL-7Rα [69, 81], thereby providing a negative modulatory feedback
into the IL-7 pathway. Negative feedback regulation of IL-7Rα expression at the
transcriptional level has also been observed in mature T-cells [106, 107], as a prominent
response triggered either by contact with IL-7 or during T-cell receptor activation by
antigen. Such negative feedback connections may help the IL-7 signaling pathway adapt to
different IL-7 baseline levels and maintain sensitivity to changes in IL-7 levels2.
From our network reconstruction, we also found examples of the kinds of incoherent
feedforward circuits that may potentially facilitate IL-7 signal adaptation on the level of T-
cell regulatory gene expression (Figure 5B, bottom). IL-7 signaling can provide negative
inputs into TCF-1, either indirectly or through Gata3 itself. However, our network
reconstruction suggests the existence of other net positive inputs from IL-7 signaling to
TCF-1, for example through Gata3-mediated antagonism of PU.1. Such opposing inputs
would form incoherent feedforward loops that may allow the expression of TCF-1 to adapt
in response to changing IL-7 levels.
The regulatory circuits discussed here respond to signal level changes in only a transient
manner – in the absence of other regulatory mechanisms, these circuits could eventually
undergo adaptation and reset their regulatory state around the new baseline signal levels. To
carry out a commitment decision, progenitors need to convert these transient responses into
stable and irreversible changes in their regulatory state, as is the case when progenitors
transition across developmental stages and make fate commitment decisions. In the next
section, we examine and discuss regulatory circuits that may enable progenitors to undergo
such stable and irreversible commitment to the T-cell fate.
Commitment and Maintenance of T-Cell Identity
In response to appropriate Notch and IL-7 signals, progenitors switch irreversibly into a
committed T-cell regulatory state, where all other non T-cell fates are silenced. This
regulatory state is upheld throughout all subsequent stages of T-cell development and
effector function, and is stably maintained even when initial Notch and IL-7 signals are no
longer present. As noted above, stable maintenance of fate identity is likely to involve action
of positive feedback loops, which are initially triggered by upstream signals and then
maintain a committed cellular state upon signal withdrawal. Positive feedback loops can
consist of a cycle of positive connections; as an example, gene X provides a positive input to
gene Y, which in turn provides a positive input back to X (Figure 2D, top). When X turns on
in response to a signal S, it up-regulates Y, which in turn feeds back to up-regulate X,
allowing it to remain on even when the signal S has been withdrawn. Alternatively, a
feedback loop that is net positive in sign can arise from mutually repressive connections
between pairs of genes; in this case, X provides a negative input to Z, which in turn provides
a negative input back to X (Figure 2D, bottom). Activation of X by S causes down-
regulation of Z, which in turn relieves X of repression by Z. This positive feedback into X
allows the circuit to stably express X while keeping Z silent at the same time. In context of
cell fate decision making, X and Z usually represent opposite fate regulatory genes that are
expressed in a mutually exclusive manner.
2We note that IL-7Rα expression levels eventually drop after commitment as the cells pass the first T-cell receptor-dependent
checkpoint to exit from the late DN3 stage. The negative feedback circuits presented here do not explain this post-commitment drop
IL-7Rα receptor levels, which more likely arises as a result of cellular responses to T-cell receptor triggering.
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The T-cell gene regulatory network revealed a number of candidate positive feedback
circuits that may play a role in enforcing stable T-cell fate commitment. However, while
positive connections exist between different T-cell regulators (e.g. TCF-1–GATA3, TCF-1–
Bcl11b) [45], we could not find complete positive feedback loops consisting of cycles of
activating connections between the T-cell regulatory genes themselves that have been
reported to date. The only apparent exceptions are the positive auto-regulatory loops
involving HEBAlt or TCF-1. The dearth of known positive loops between T-cell regulatory
genes, which is apparent from the network reconstruction (Figure 4), stands in contrast to
other developmental systems, notably the B-cell developmental network, where key fate
regulators positively regulate each other [38, 108]. Instead, most positive feedback loops
here involve mutual repression between T-cell regulatory genes and stem cell or alternate
fate genes (Figure 5C). Gfi1, TCF-1 and Bcl11b all form mutually antagonistic loops with
PU.1 (Figure 5C). E proteins may also participate in some of these positive feedback loops –
HEB/E2A dimers positively regulate Gfi1, and are also negatively regulated by PU.1, either
through transcriptional repression or through up-regulation of Id2, an E protein inhibitor and
PU.1 target. Mutual antagonism between these T-cell regulatory genes and PU.1 may enable
progenitors to maintain a stable regulatory state where T-cell identity genes are expressed,
and stem and alternate fate genes such as PU.1 are silenced. As many of the T-cell
regulatory genes discussed here also participate in IL-7 and Notch signal detection (see
above), they are good candidates for mediating commitment in response to upstream signals.
Conclusion and Future Directions
Here, we have presented a new model of the gene regulatory network underlying T-cell
development in haematopoietic progenitor cells. Using this network reconstruction, we have
identified candidate regulatory gene circuits for facilitating the following aspects of the T-
cell fate decision making process: 1) Detection of persistence in Notch-Delta signaling, 2)
Detection of IL-7 signal level changes, and 3) Maintenance of T-cell identity and silencing
of alternate cell fates upon commitment. These regulatory circuits provide a basis for
understanding how regulatory genes work together to mediate a developmental cell fate
decision.
To further understand these regulatory gene circuits, experiments will need to be performed
that probe their structure and function. The gene circuits we describe here contain many
connections not yet tested on a cis-regulatory level (Figure 4, dashed and dotted lines). To
validate regulatory gene circuit structure, it will be necessary to determine whether these
connections indeed represent direct regulatory inputs; if not, the identities of the regulatory
genes that do mediate these indirect connections will need to be resolved. This knowledge is
particularly important for validating the structure of coherent feedforward loops (Figure
5A), where an apparent feedforward input into a gene could in fact be mediated completely
through the second coincident input. One way to test whether a transcription factor targets a
gene directly is to determine whether it binds to sites on the target gene locus. Transcription
factor binding sites can now be identified on a genome-wide level using chromatin
immunoprecipitation followed by high-throughput sequencing (ChIP-Seq), and this
approach has been used to elucidate the structure of the regulatory networks underlying B-
and myeloid cell development [50, 51]. We are currently using ChIP-Seq to determine the
binding sites and putative target genes of different transcription factors at several finely-
divided sub-stages in T-cell development (J. Zhang, A. Mortazavi, B. Williams, B. J. Wold,
and E. V. Rothenberg, in preparation). This approach is yielding insights not only into the
structure of the T-cell regulatory network, but also its dynamic behavior during the process
of fate commitment.
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Validating a direct regulatory connection between a transcription factor and its putative
target requires not only evidence for transcription factor binding on the gene locus, but also
evidence that the binding site is active during development. To show that a binding site is
active, it is important to show that its mutation or removal affects proper regulation of the
target gene. Binding site mutagenesis can be performed on endogenous gene loci using gene
targeting [109], or, alternatively, on reporter transgenes [110]. The transcription factor itself
also needs to be shown to act on the binding site to control target gene expression, and to
exert its gain and loss of function effects in a target element-dependent way. These types of
experiments are needed to validate the structure of the proposed regulatory circuits, and also
to identify new circuits possibly involved in fate decision making.
To examine the function of these regulatory gene circuits, gene circuit activity will
eventually need to be followed closely over time, under conditions where input signal levels
and/or regulatory gene expression levels are varied in a quantitative manner. Such close
monitoring of gene circuit activity has been greatly facilitated by the development of
fluorescent gene expression reporters, which allow expression levels of individual genes to
be measured in single cells in a quantitative and non-invasive manner [111, 112]. For
regulatory circuits involved in processing Notch-Delta or IL-7 signals, measurements of
their input/output relationships will yield insights into the signal processing operations that
they perform. Furthermore, input/output measurements performed in conjunction with gene
perturbations that alter connectivity of these circuits will enable direct tests of the roles of
circuit structure in signal processing. Similar measurements will also yield insights into the
behavior of positive feedback circuits mediating cell fate commitment. For example, signal
levels can be experimentally varied and the effects on the levels of gene expression within
the positive feedback loop measured, to assess the stability of a positive feedback loop to
fluctuating signals. Furthermore, by perturbing genes and connections within the positive
feedback loop and measuring resultant changes in circuit activity, it will be possible to
determine their roles in maintaining regulatory state stability. Such experiments will help to
develop an understanding of how regulatory gene circuits mediate different aspects of the
cell fate decision making process, and more generally, how they function during mammalian
development.
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Figure 1.
Stages of T-cell specification and commitment. Double negative (CD4-CD8-DN)
developmental stages before T-cell fate commitment (Phase 1), and immediately after
commitment (Phase 2) are shown. Straight arrows represent signal-dependent developmental
transitions between successive stages, and the curved arrow represents cytokine-dependent
proliferation in the Phase 1 stage. Gray dashed lines represent the commitment checkpoint
(left), and two TCR-dependent developmental checkpoints (right). [all figures are original]
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Figure 2.
Regulatory circuit motifs. A) Coherent feedforward loop. B) Negative feedback loop (top).
C) Incoherent feedforward loop. D) Positive feedback loop, consisting of a cycle of positive
connections (top), or a cycle of repressive connections (bottom). In the former circuit, X and
Y correspond to regulators of the same fate; in the latter circuit, X and Z are regulators of
alternate fates that are expressed in a mutually exclusive manner (bottom).
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Figure 3.
Strategies used for inferring regulatory gene connections. A) Natural developmental
progression, showing developmental stages of interest. B) In vivo conditional or germline
deletion experiments. Upper: ideal in vivo stage-specific gene deletion experiment, where
development before the stage of interest is not compromised and compensatory mechanisms
do not come into play. Lower: Complication of in vivo germline or conditional deletion
experiments, if normal developmental sequence is deranged long before the stages of
interest. Gene expression pattern in cell state generated as a result of altered developmental
progression (yellow circle) is not strictly comparable with control. C) In vitro T-cell
differentiation experiment. Short-term effects of stage-specific environmental signal or gene
perturbations (gain or loss of function) remain comparable with controls. Altered cell state
(yellow circle), in some cases transformation to a different lineage, can be generated due to
prolonged effects of the applied perturbations. Gene expression in such cases may not
simply reflect gain or loss of function of the targeted regulator. Dosage effects (not shown)
can also yield developmentally inappropriate responses.
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Figure 4.
Reconstruction of the T-Cell Developmental Gene Regulatory Network. Regulatory network
encompasses Notch signaling (blue), IL-7 signaling (dark green), pre-TCR signaling (gray),
T-cell regulatory genes (light green), and stem and alternate fate regulatory genes (red). T-
cell regulatory genes sharply up-regulated prior to commitment are enclosed in a yellow
box. Genes and connections active during the earlier T-cell developmental stages are placed
to the left, whereas genes and connections active during later stages are placed to the right.
The prevailing connections between the genes in different groups and their signs are
summarized in the inset. An online version of this network is available at
http://www.its.caltech.edu/~tcellgrn/.
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Figure 5.
Regulatory Gene Circuits Underlying T-Cell Fate Decision Making. A) Coherent
feedforward loops for detection of persistent Notch signaling. Shown here are coherent
feedforward loops mediating inputs from Notch signaling to Bcl11b (left), as well as to
CD25, pTa and Rag1 (right). B) Incoherent feedforward loops and negative feedback loops
for detection of IL-7 signal level changes. Shown here is a negative feedback loop regulating
expression of IL-7Ra (top), and an incoherent feedforward loop regulating expression of
Tcf7 and Lef1 (bottom). C) Positive feedback loops for T-cell fate commitment and
exclusion of alternate fates. Shown here are a series of positive feedback loops involving
mutual repression between PU.1 and the T-cell regulators TCF-1, Bcl11b, E2A/HEB and
Gfi1. Note that TCF-1, Bcl11b, PU.1, HEBAlt and E2A also receive inputs from Notch and/
or IL-7 signaling and may hence mediate engagement of the positive feedback loops in
response to upstream signals.
Kueh and Rothenberg Page 22
Wiley Interdiscip Rev Syst Biol Med. Author manuscript; available in PMC 2013 January 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
